feed icon

Cumberland takes Caldolor Down Under

Posted on October 29, 2009 at 1:43 pm

Four months after receiving approval to sell its injectable ibuprofen in the United States, Cumberland Pharmaceuticals has signed a licensing deal to market the product in Australia and New Zealand. The Nashville company will step back and let Phebra handle the regulatory and marketing work there while receiving a cut in sales.

Comments

Leave a Reply




Recent Comments

The Conglomerate